Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-27T03:50:50.248Z Has data issue: false hasContentIssue false

12 - Immunosecretory disorders/plasma cell disorders and lymphoplasmacytic lymphoma

Published online by Cambridge University Press:  07 August 2009

Attilio Orazi
Affiliation:
Indiana University
Dennis P. O'Malley
Affiliation:
Indiana University
Daniel A. Arber
Affiliation:
Stanford University, California
Get access

Summary

Introduction

Immunosecretory and plasma cell disorders cover a broad spectrum of clinical and pathologic entities. Some of the processes, such as monoclonal gammopathy of undetermined significance (MGUS), have relatively indolent behavior, while others, such as plasma cell leukemia, are associated with very poor prognosis and high mortality. This group of disorders includes lymphoplasmacytic lymphoma (LPL), a neoplastic entity which overlaps both with B-cell lymphoma and with the immunosecretory disorders group.

Benign plasma cells and reactive plasmacytosis

Plasma cells are a normal component of adult bone marrows. They typically represent about 0–1% of the overall cellularity seen in bone marrow aspirate smears (Foucar, 2001). Levels above 5% are considered abnormal in immunologically unstimulated marrows. In normal bone marrow biopsies, plasma cells are most typically located in perivascular locations.

In Wright–Giemsa-stained preparations, plasma cells have a distinctive, light to dark blue cytoplasm with an eccentrically placed nucleus. The nuclear chromatin is quite dense, and in appropriately thin histologic sections is classically described as “clockface chromatin.” Adjacent to the nucleus is a clearing in the cytoplasm, referred to as a hof, which represents the Golgi apparatus of the cell.

The cytologic features of benign and malignant plasma cells can overlap (Fig. 12.1). Inclusions which may be seen in plasma cells include Russell bodies, which are globular eosinophilic collections of immunoglobulin in the cytoplasm. Dutcher bodies are not true nuclear inclusions but rather cytoplasmic inclusions that overlie the nucleus. Dutcher bodies are only rarely seen in benign proliferations of plasma cells.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chu, P. G., Arber, D. A., & Weiss, L. M. (2003). Expression of T/NK cell and plasma cell antigens in non-hematopoietic epithelioid neoplasms: an immunohistochemical study of 447 cases. American Journal of Clinical Pathology, 120, 64–70.CrossRefGoogle Scholar
Drach, J., Gattringer, C., Glassl, H., Drach, D., & Huber, H. (1992). The biological and clinical significance of the KI-67 growth fraction in multiple myeloma. Hematological Oncology, 10, 125–34.CrossRefGoogle ScholarPubMed
Drach, J., Kaufmann, H., Urbauer, E., Schreiber, S., Ackermann, J., & Huber, H. (2000). The biology of multiple myeloma. Journal of Cancer Research and Clinical Oncology, 126, 441–7.CrossRefGoogle ScholarPubMed
Fletcher, C. D. M., Unni, K. K., & Mertens, F., eds. (2002). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon:IARC Press.Google Scholar
Fonseca, R., Blood, E., Rue, M., et al. (2003). Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood, 101, 4569–75.CrossRefGoogle Scholar
Foucar, K. (2001). Bone Marrow Pathology, 2nd edn. Chicago, IL: ASCP Press.Google Scholar
Gavarotti, P., Boccadoro, M., Redoglia, V., Golzio, F., & Pileri, A. (1985). Reactive plasmacytosis: case report and review of the literature. Acta Haematologica, 73, 108–10.CrossRefGoogle ScholarPubMed
Greipp, P. R., Leong, T., Bennett, J. M., et al. (1998). Plasmablastic morphology: an independent prognostic factor with clinical and laboratory correlates. Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486. Blood, 7, 2501–7.Google Scholar
Jaffe, E. S., Harris, N. L., Stein, H., & Vardiman, J. W., eds. (2001). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press.Google Scholar
Kass, L. & Kapadia, I. H. (2001). Perivascular plasmacytosis: a light-microscopic and immunohistochemical study of 93 bone marrow biopsies. Acta Haematologica, 105, 57–63.CrossRefGoogle ScholarPubMed
Kyle, R. A. (2003). Plasma cell disorders. In Atlas of Clinical Hematology, ed. Armitage., J. O.Philadelphia, PA: Lippincott, Williams & Wilkins, pp. 119–36.Google Scholar
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., et al. (2002). A long-term study of prognosis in monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 346, 564–9.CrossRefGoogle ScholarPubMed
Nishimoto, Y., Iwahashi, T., Nishihara, T., et al. (1987). Hepatitis-associated aplastic anemia with systemic plasmacytosis. Acta Pathologica Japonika, 37, 155–66.Google ScholarPubMed
O'Connell, F. P., Pinkus, J. L., & Pinkus, G. S. (2004). CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. American Journal of Clinical Pathology, 121, 254–63.CrossRefGoogle Scholar
Poje, E. J., Soori, G. S., & Weisenburger, D. D. (1992). Systemic polyclonal B-immunoblastic proliferation with marked peripheral blood and bone marrow plasmacytosis. American Journal of Clinical Pathology, 98, 222–6.CrossRefGoogle ScholarPubMed
Rajkumar, S. V., Fonseca, R., Lacy, M. Q., et al. (1999). Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplant for multiple myeloma. Journal of Clinical Oncology, 17, 1551–7.CrossRefGoogle ScholarPubMed
Schwartz, T. H., Rhiew, R., Isaacson, S. R., Orazi, A., & Bruce, J. N. (2001). Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study. Neurosurgery, 49, 1039–45.Google ScholarPubMed
Swan, N., Skinner, M., & O'Hara, C. J. (2003). Bone marrow core biopsy specimens in AL (primary) amyloidosis: a morphologic and immunohistochemical study of 100 cases. American Journal of Clinical Pathology, 120, 610–16.CrossRefGoogle ScholarPubMed
Wolf, B. C., Kumar, A., Vera, J. C., & Neiman, R. S. (1986). Bone marrow morphology and immunology in systemic amyloidosis. American Journal of Clinical Pathology, 86, 84–8.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×